Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.
Primary care clinicians are most likely to encounter patients harboring early, subclinical cardiac changes. Historically, however, they have lacked objective tools to identify such patients. Now Ventric Health offers an FDA-cleared screening tool called Vivio, to catch early signs of heart failure, to interrupt the course of this degenerative condition. A companion article to "Innovating Heart Failure: Start-Ups Harness Natural Pathways."
Rick Abramson picked to lead FDA’s Digital Health Center of Excellence. Excerpted from Pathways’ Picks Febraury 25: Tariff Topsy-Turvy, CPT Panel Decisions, Reliance in South Africa.